⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2755800 | 0.73 | — | — | |
| SCHEMBL976981 | 0.69 | — | — | |
| SCHEMBL4743548 | 0.67 | — | — | |
| SCHEMBL3073245 | 0.67 | — | — | |
| SCHEMBL3117258 | 0.67 | — | — | |
| SCHEMBL4645948 | 0.63 | — | — | |
| SCHEMBL7406045 | 0.62 | — | — | |
| SCHEMBL9569884 | 0.62 | — | — | |
| SCHEMBL18609566 | 0.60 | — | — | |
| SCHEMBL13257573 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 174 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117500783-A | Perfume compounds | 奇华顿股份有限公司 | 2024-02-02 | — | — | CN | claimed |
| CN-115806554-A | Preparation and application of colon-targeted prodrug and drug delivery system thereof | 沈阳海诺威医药科技有限公司 | 2023-03-17 | — | — | CN | claimed |
| CN-115368507-B | Amorphous fluoropolymers, compositions containing them, and methods of making and using them | 山东华夏神舟新材料有限公司 | 2023-01-03 | — | — | CN | claimed |
| WO-2022261956-A1 | FRAGRANCE COMPOUNDS | GIVAUDAN SA (CH) | 2022-12-22 | — | — | WO | claimed |
| CN-115368507-A | Amorphous fluoropolymer, composition containing same, and preparation method and application thereof | 山东华夏神舟新材料有限公司 | 2022-11-22 | — | — | CN | claimed |
| EP-3774813-A1 | PYRAZOLOTRIAZOLOPYRIMIDINE DERIVATIVES AS A2A RECEPTOR ANTAGONIST | BeiGene, Ltd. (KY) | 2021-02-17 | — | — | EP | claimed |
| CN-111187262-A | Imidazo [1,2-a ] pyridine derivative and preparation method and application thereof | 沈阳药科大学 | 2020-05-22 | — | — | CN | claimed |
| WO-2019196803-A1 | PYRAZOLOTRIAZOLOPYRIMIDINE DERIVATIVES AS A2A RECEPTOR ANTAGONIST | BEIGENE, LTD. (KY) | 2019-10-17 | — | — | WO | claimed |
| WO-2007096740-A2 | NOVEL CEPHALOSPORINS | ORCHID RESEARCH LABORATORIES LIMITED (IN) | 2007-08-30 | — | — | WO | claimed |
| WO-2007028524-A2 | USE OF A DERIVATIVE OF IMIDAZOLE FOR THE TREATMENT OF LEUKOTRIENE RELATED DISORDERS | PROUS INSTITUTE FOR BIOMEDICAL RESEARCH S.A. (ES) | 2007-03-15 | — | — | WO | claimed |
| WO-2001089495-A2 | ANTIBIOTIC COMPOSITIONS CONTAINING QUINOLONE DERIVATIVES FOR TREATMENT OF THE EYE, EAR AND NOSE | ALCON LABORATORIES, INC. (US) | 2001-11-29 | — | — | WO | claimed |
| CN-1238774-A | Pyridobenzoxazine derwatives | DAIICHI SEIYAKU CO (JP) | 1999-12-15 | — | — | CN | claimed |
| US-5686459-A | ANTICOAGULANTS | HOFFMANN-LA ROCHE INC. (US) | 1997-11-11 | — | — | US | claimed |
| EP-4651872-A1 | COMPOUNDS, COMPOSITIONS AND METHODS OF USE TO TREAT HYPOPARATHYROIDISM AND OSTEOPOROSIS | Septerna, Inc. (US) | 2025-11-26 | — | — | EP | disclosed |
| WO-2025230799-A2 | CYCLOALKYL- AND PIPERIDINYL-CONTAINING DIAMINOMETHYLENE PYRIMIDINE-2,4,6-TRIONE AGONISTS OF PARATHYROID HORMONE 1 AND INCRETIN RECEPTORS | SEPTERNA, INC. (US) | 2025-11-06 | — | — | WO | disclosed |
| CN-115068468-B | Carboxylic aromatic amides as bradykinin B1 receptor antagonists | 拜耳制药股份公司 | 2025-02-25 | — | — | CN | disclosed |
| CN-1238774-A | Pyridobenzoxazine derwatives | DAIICHI SEIYAKU CO (JP) | 1999-12-15 | — | — | CN | disclosed |
| WO-1999050268-A2 | SUBSTITUTED INDOLEALKANOIC ACIDS | THE INSTITUTES FOR PHARMACEUTICAL DISCOVERY, INC. (US) | 1999-10-07 | — | — | WO | disclosed |
| US-5686459-A | ANTICOAGULANTS | HOFFMANN-LA ROCHE INC. (US) | 1997-11-11 | — | — | US | disclosed |
| EP-0430037-A2 | Process for producing 2-carbon-substituted carbapenem derivatives | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1991-06-05 | — | — | EP | disclosed |